DAVID PENDARVIS - 16 Nov 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Administrative Officer
Signature
David Pendarvis, Chief Administrative Officer
Issuer symbol
RMD
Transactions as of
16 Nov 2021
Net transactions value
+$1,949,806
Form type
4
Filing time
18 Nov 2021, 15:04:05 UTC
Previous filing
15 Nov 2021
Next filing
22 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Award $4,409,997 +17,307 +16% $254.81 127,792 16 Nov 2021 Direct F1
transaction RMD ResMed Common Stock Tax liability $2,460,191 -9,655 -7.6% $254.81 118,137 17 Nov 2021 Direct F2
transaction RMD ResMed Common Stock Award $0 +986 +0.83% $0.000000 119,123 18 Nov 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on November 16, 2021, when the compensation committee certified that the performance metrics were met.
F2 Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018.
F3 Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on November 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.